pubmed-article:6778386 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6778386 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:6778386 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:6778386 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:6778386 | pubmed:dateCreated | 1981-2-19 | lld:pubmed |
pubmed-article:6778386 | pubmed:abstractText | Treatment of fortimicin B with lithium in ethylamine gave 3-O-demethylfortimicin B. The latter was converted by methodology developed with fortimicin B to 3-O-demethylfortimicin A, 4-N-sarcosyl-3-O-demethylfortimicin B, 4-N-beta-alanyl-3-O-demethylfortimicin B, and 4-N-(beta-aminoethyl)-3-O-demethylfortimicin B. 3-O-demethylfortimicin A and the 4-N-acyl-3-O-demethylfortimicins B had appreciably higher antibacterial activities than the corresponding parent fortimicins. Most significant was the increased activity of 3-O-demethylfortimicin A relative to fortimicin A against a variety of strains of Pseudomonas aeruginosa. | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:language | eng | lld:pubmed |
pubmed-article:6778386 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6778386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6778386 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6778386 | pubmed:month | Nov | lld:pubmed |
pubmed-article:6778386 | pubmed:issn | 0066-4804 | lld:pubmed |
pubmed-article:6778386 | pubmed:author | pubmed-author:GoldsteinAA | lld:pubmed |
pubmed-article:6778386 | pubmed:author | pubmed-author:JohnsonPP | lld:pubmed |
pubmed-article:6778386 | pubmed:author | pubmed-author:MartinJ RJR | lld:pubmed |
pubmed-article:6778386 | pubmed:author | pubmed-author:TadanierJJ | lld:pubmed |
pubmed-article:6778386 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6778386 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:6778386 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6778386 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6778386 | pubmed:pagination | 761-5 | lld:pubmed |
pubmed-article:6778386 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:6778386 | pubmed:meshHeading | pubmed-meshheading:6778386-... | lld:pubmed |
pubmed-article:6778386 | pubmed:meshHeading | pubmed-meshheading:6778386-... | lld:pubmed |
pubmed-article:6778386 | pubmed:meshHeading | pubmed-meshheading:6778386-... | lld:pubmed |
pubmed-article:6778386 | pubmed:meshHeading | pubmed-meshheading:6778386-... | lld:pubmed |
pubmed-article:6778386 | pubmed:year | 1980 | lld:pubmed |
pubmed-article:6778386 | pubmed:articleTitle | Synthesis of 3-O-demethylfortimicins. | lld:pubmed |
pubmed-article:6778386 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6778386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6778386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6778386 | lld:pubmed |